Ramtin Agah is Chief Medical Officer of RenovoRx, Inc.. Currently has a direct ownership of 47,460 shares of RNXT, which is worth approximately $61,223. The most recent transaction as insider was on Jan 26, 2024, when has been sold 40,983 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 47.5K
0% 3M change
632.75% 12M change
Total Value Held $61,223

Ramtin Agah Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 26 2024
BUY
Open market or private purchase
-
40,983 Added 46.34%
47,460 Common Stock
Jun 07 2022
BUY
Open market or private purchase
$10,001 $1.93 p/Share
5,182 Added 44.45%
6,477 Common Stock
Mar 16 2022
SELL
Bona fide gift
-
975,000 Reduced 99.87%
1,295 Common Stock
Aug 30 2021
BUY
Conversion of derivative security
-
1,295 Added 0.13%
976,295 Common Stock
RA

Ramtin Agah

Chief Medical Officer
Los Altos,, CA

Track Institutional and Insider Activities on RNXT

Follow RenovoRx, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RNXT shares.

Notify only if

Insider Trading

Get notified when an Renovo Rx, Inc. insider buys or sells RNXT shares.

Notify only if

News

Receive news related to RenovoRx, Inc.

Track Activities on RNXT